Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia

Bone Marrow Transplant. 1989 May;4(3):331-3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation*
  • Busulfan / administration & dosage
  • Child
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Female
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Transplantation, Autologous

Substances

  • Cyclophosphamide
  • Busulfan